Publication:
A point mutation of zebrafish c-cbl gene in the ring finger domain produces a phenotype mimicking human myeloproliferative disease

Thumbnail Image

Date

2015

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Nature
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Peng, X, M Dong, L Ma, X-E Jia, J Mao, C Jin, Y Chen, et al. 2015. “A Point Mutation of Zebrafish c-Cbl Gene in the Ring Finger Domain Produces a Phenotype Mimicking Human Myeloproliferative Disease.” Leukemia 29 (12) (June 24): 2355–2365. doi:10.1038/leu.2015.154.

Research Data

Abstract

Controlled self-renewal and differentiation of hematopoietic stem/progenitor cells (HSPCs) are critical for vertebrate development and survival. These processes are tightly regulated by the transcription factors, signaling molecules and epigenetic factors. Impaired regulations of their function could result in hematological malignancies. Using a large-scale zebrafish N-ethyl-N-nitrosourea mutagenesis screening, we identified a line named LDD731, which presented significantly increased HSPCs in hematopoietic organs. Further analysis revealed that the cells of erythroid/myeloid lineages in definitive hematopoiesis were increased while the primitive hematopoiesis was not affected. The homozygous mutation was lethal with a median survival time around 14-15 days post fertilization. The causal mutation was located by positional cloning in the c-cbl gene, the human ortholog of which, c-CBL, is found frequently mutated in myeloproliferative neoplasms (MPN) or acute leukemia. Sequence analysis showed the mutation in LDD731 caused a histidine-to-tyrosine substitution of the amino acid codon 382 within the RING finger domain of c-Cbl. Moreover, the myeloproliferative phenotype in zebrafish seemed dependent on the Flt3 (fms-like tyrosine kinase 3) signaling, consistent with that observed in both mice and humans. Our study may shed new light on the pathogenesis of MPN and provide a useful in vivo vertebrate model of this syndrome for screening drugs.Leukemia advance online publication, 14 July 2015; doi:10.1038/leu.2015.154.

Description

Other Available Sources

Keywords

hematopoietic stem/progenitor cells, c-cbl, myeloproliferative neoplasms (MPN), flt3, N-ethyl-N-nitrosourea (ENU) mutagenesis screening

Terms of Use

This article is made available under the terms and conditions applicable to Open Access Policy Articles (OAP), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories